LP
AXSM icon

LMR Partners’s Axsome Therapeutics AXSM Stock Holding History

LMR Partners’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-72,200
Closed -$6.11M – 1377
2024
Q4 		$6.11M Buy
+72,200
New +$6.64M 0.05% 342

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

LMR Partners's AXSM Position: Q2 2026 in Review

LMR Partners opened a new position in Axsome Therapeutics (AXSM) in Q2 2026: 4,974 shares worth $1.22M. The stake represents ﹤0.01% of the portfolio and ranks #1014 among its holdings. This is a return to the name: LMR Partners previously reported a position in AXSM as recently as Q2 2020.

LMR Partners first reported a position in AXSM in Q2 2017 and has held it in 3 quarters since. 506 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • LMR Partners held 4,974 shares of Axsome Therapeutics worth $1.22M as of Q2 2026.
  • Axsome Therapeutics was a new LMR Partners position in Q2 2026.
  • Axsome Therapeutics made up ﹤0.01% of LMR Partners's portfolio in Q2 2026, its #1014 holding.
  • LMR Partners first reported a position in Axsome Therapeutics in Q2 2017 and has held it in 3 quarters since.
  • 506 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on LMR Partners's 13F filing for Q2 2026, filed 14 Aug 2026.